$FSI
FLEXIBLE SOLUTIONS INTERNATIONAL INC Stock $fsi

$fsi Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000149315223017255 Filed on May 15, 2023

Income Statement

Concept	2023 Q2	2023 Q1
Revenue	$10.33M	$9.848M
YoY Change	-7.47%	-8.68%
Cost Of Revenue	$7.292M	$6.763M
YoY Change	-0.15%	-3.0%
Gross Profit	$3.039M	$3.085M
YoY Change	-21.31%	-19.07%
Gross Profit Margin	29.41%	31.33%
Selling, General & Admin	$1.842M	$1.744M
YoY Change	-4.74%	25.1%
% of Gross Profit	60.63%	56.52%
Research & Development	$15.83K	$21.50K
YoY Change	-40.39%	21.51%
% of Gross Profit	0.52%	0.7%
Depreciation & Amortization	$408.8K	$302.8K
YoY Change	70.47%	60.75%
% of Gross Profit	13.45%	9.82%
Operating Expenses	$1.988M	$1.903M
YoY Change	-1.25%	28.5%
Operating Profit	$1.051M	$1.182M
YoY Change	-43.14%	-49.28%
Interest Expense	$115.5K	$134.9K
YoY Change	121.52%	134.08%
% of Operating Profit	10.99%	11.41%
Other Income/Expense, Net
YoY Change
Pretax Income	$1.349M	$1.264M
YoY Change	-43.11%	-47.1%
Income Tax	$354.4K	$299.8K
% Of Pretax Income	26.27%	23.71%
Net Earnings	$809.9K	$884.4K
YoY Change	-51.28%	-42.31%
Net Earnings / Revenue	7.84%	8.98%
Basic Earnings Per Share	$0.07	$0.07
Diluted Earnings Per Share	$0.06	$0.07
COMMON SHARES
Basic Shares Outstanding	12.44M shares	12.44M shares
Diluted Shares Outstanding	12.52M shares	12.53M shares

Balance Sheet

Concept	2023 Q2	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$7.414M	$5.530M
YoY Change	65.17%	2.95%
Cash & Equivalents	$7.414M	$5.530M
Short-Term Investments
Other Short-Term Assets	$1.879M	$1.332M
YoY Change	18.38%	-29.36%
Inventory	$11.32M	$14.38M
Prepaid Expenses	$868.9K	$331.8K
Receivables	$7.435M	$10.83M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$28.04M	$32.08M
YoY Change	0.43%	9.05%
LONG-TERM ASSETS
Property, Plant & Equipment	$12.82M	$9.620M
YoY Change	44.56%	95.52%
Goodwill	$2.534M	$2.534M
YoY Change	0.0%	0.0%
Intangibles	$2.360M	$2.400M
YoY Change	-6.35%	-6.25%
Long-Term Investments	$6.256M	$5.529M
YoY Change	13.99%	1.39%
Other Assets	$274.3K	$274.3K
YoY Change	2059.76%	2059.76%
Total Long-Term Assets	$24.76M	$20.86M
YoY Change	26.12%	32.87%
TOTAL ASSETS
Total Short-Term Assets	$28.04M	$32.08M
Total Long-Term Assets	$24.76M	$20.86M
Total Assets	$52.80M	$52.94M
YoY Change	11.03%	17.34%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.634M	$1.473M
YoY Change	-15.22%	8.1%
Accrued Expenses	$734.6K	$181.4K
YoY Change	-40.28%	-86.24%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$3.664M
YoY Change	-100.0%	-25.97%
Long-Term Debt Due	$738.9K	$719.6K
YoY Change	5.52%	8.11%
Total Short-Term Liabilities	$8.093M	$10.85M
YoY Change	-27.21%	-21.93%
LONG-TERM LIABILITIES
Long-Term Debt	$7.302M	$5.257M
YoY Change	53.28%	252.49%
Other Long-Term Liabilities	$82.74K	$96.01K
YoY Change	-38.39%	-34.54%
Total Long-Term Liabilities	$7.302M	$5.257M
YoY Change	53.28%	252.49%
TOTAL LIABILITIES
Total Short-Term Liabilities	$8.093M	$10.85M
Total Long-Term Liabilities	$7.302M	$5.257M
Total Liabilities	$15.98M	$16.70M
YoY Change	-3.17%	5.41%
SHAREHOLDERS EQUITY
Retained Earnings	$16.97M	$16.79M
YoY Change	40.52%	61.19%
Common Stock	$12.44K	$12.44K
YoY Change	0.41%	0.47%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$34.14M	$33.55M
YoY Change
Total Liabilities & Shareholders Equity	$52.80M	$52.94M
YoY Change	11.03%	17.34%

Cashflow Statement

Concept	2023 Q2	2023 Q1
OPERATING ACTIVITIES
Net Income	$809.9K	$884.4K
YoY Change	-51.28%	-42.31%
Depreciation, Depletion And Amortization	$408.8K	$302.8K
YoY Change	70.47%	60.75%
Cash From Operating Activities	$8.155M	-$228.2K
YoY Change	153.45%	-90.59%
INVESTING ACTIVITIES
Capital Expenditures	$3.933M	$213.1K
YoY Change	-1702.65%	20.59%
Acquisitions
YoY Change
Other Investing Activities	$72.75K	-$342.8K
YoY Change	-118.28%	-4670.0%
Cash From Investing Activities	-$3.860M	-$555.8K
YoY Change	499.87%	228.52%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net		$177.6K
YoY Change		-15.26%
Cash From Financing Activities	-2.628M	$666.4K
YoY Change	-23.94%	-69.89%
NET CHANGE
Cash From Operating Activities	8.155M	-$228.2K
Cash From Investing Activities	-3.860M	-$555.8K
Cash From Financing Activities	-2.628M	$666.4K
Net Change In Cash	1.667M	-$284.9K
YoY Change	-289.22%	-15.86%
FREE CASH FLOW
Cash From Operating Activities	$8.155M	-$228.2K
Capital Expenditures	$3.933M	$213.1K
Free Cash Flow	$4.222M	-$441.3K
YoY Change	21.93%	-83.04%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001069394
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments		usd
CY2023Q1	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders		usd
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet		usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet		usd
CY2023Q1	us-gaap	Revenue Related And Nonrelated Party Status Extensible Enumeration RevenueRelatedAndNonrelatedPartyStatusExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022	us-gaap	Revenue Related And Nonrelated Party Status Extensible Enumeration RevenueRelatedAndNonrelatedPartyStatusExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2023Q1	us-gaap	Accounts Receivable After Allowance For Credit Loss Related And Nonrelated Party Status Extensible Enumeration AccountsReceivableAfterAllowanceForCreditLossRelatedAndNonrelatedPartyStatusExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q4	us-gaap	Accounts Receivable After Allowance For Credit Loss Related And Nonrelated Party Status Extensible Enumeration AccountsReceivableAfterAllowanceForCreditLossRelatedAndNonrelatedPartyStatusExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2023Q1	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt		usd
CY2023Q1	FSI	Proceeds From Loan Acquired From Acquisition ProceedsFromLoanAcquiredFromAcquisition		usd
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-31540
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	FLEXIBLE SOLUTIONS INTERNATIONAL INC.
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	71-1630889
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	6001 54 Ave.
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Taber
CY2023Q1	dei	Entity Address Country EntityAddressCountry	CA
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	T1G 1X4
CY2023Q1	dei	City Area Code CityAreaCode	(403)
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	223-2995
CY2023Q1	dei	Security12b Title Security12bTitle	Common Stock, $0.001 par value
CY2023Q1	dei	Trading Symbol TradingSymbol	FSI
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NYSEAMER
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	12435532	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5530178	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6115099	usd
CY2023Q1	us-gaap	Deposits Assets Current DepositsAssetsCurrent	1000000	usd
CY2022Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	700000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	10833527	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	9449857	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	14379823	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	14419430	usd
CY2023Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	331794	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	310297	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	32075322	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	30994683	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	9619538	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	9709288	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	154447	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	167222	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2400000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2440000	usd
CY2023Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	351287	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	8540	usd
CY2023Q1	us-gaap	Equity Method Investments EquityMethodInvestments	5528890	usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	5458895	usd
CY2023Q1	us-gaap	Goodwill Goodwill	2534275	usd
CY2022Q4	us-gaap	Goodwill Goodwill	2534275	usd
CY2023Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	274289	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	274289	usd
CY2023Q1	us-gaap	Assets Assets	52938048	usd
CY2022Q4	us-gaap	Assets Assets	51587192	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1473180	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	873904	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	181430	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	959856	usd
CY2023Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	114540	usd
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	387763	usd
CY2023Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	4638927	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	4486350	usd
CY2023Q1	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	3663504	usd
CY2022Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	2818591	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	58440	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	58080	usd
CY2023Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	719607	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	717612	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	10849628	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	10302156	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	96007	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	109142	usd
CY2023Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	500459	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	500459	usd
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	5256831	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	5436465	usd
CY2023Q1	us-gaap	Liabilities Liabilities	16702925	usd
CY2022Q4	us-gaap	Liabilities Liabilities	16348222	usd
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	12435532	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	12435532	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	12426260	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	12426260	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	12436	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	12426	usd
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	12436	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	12426	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	17722233	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	17523345	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-973038	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-805799	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	16788333	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	15903964	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	33549964	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	32633936	usd
CY2023Q1	us-gaap	Minority Interest MinorityInterest	2685159	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	2605034	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	36235123	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	35238970	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	52938048	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	51587192	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	9847517	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10783280	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	6762525	usd
CY2022Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	6971379	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	3084992	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	3811901	usd
CY2023Q1	us-gaap	Salaries And Wages SalariesAndWages	671692	usd
CY2022Q1	us-gaap	Salaries And Wages SalariesAndWages	623503	usd
CY2023Q1	us-gaap	Officers Compensation OfficersCompensation	393014	usd
CY2022Q1	us-gaap	Officers Compensation OfficersCompensation	233585	usd
CY2023Q1	us-gaap	General Insurance Expense GeneralInsuranceExpense	201530	usd
CY2022Q1	us-gaap	General Insurance Expense GeneralInsuranceExpense	185360	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	134870	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	57618	usd
CY2023Q1	us-gaap	Other General Expense OtherGeneralExpense	98846	usd
CY2022Q1	us-gaap	Other General Expense OtherGeneralExpense	35970	usd
CY2023Q1	FSI	Investor Relations And Transfer Agent Fee InvestorRelationsAndTransferAgentFee	89892	usd
CY2022Q1	FSI	Investor Relations And Transfer Agent Fee InvestorRelationsAndTransferAgentFee	37097	usd
CY2023Q1	FSI	Consulting Consulting	62977	usd
CY2022Q1	FSI	Consulting Consulting	76274	usd
CY2023Q1	us-gaap	Professional Fees ProfessionalFees	62767	usd
CY2022Q1	us-gaap	Professional Fees ProfessionalFees	50581	usd
CY2023Q1	us-gaap	Travel And Entertainment Expense TravelAndEntertainmentExpense	61652	usd
CY2022Q1	us-gaap	Travel And Entertainment Expense TravelAndEntertainmentExpense	44808	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	48398	usd
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	40029	usd
CY2023Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	25295	usd
CY2022Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	42225	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	21502	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	17696	usd
CY2023Q1	us-gaap	Communications And Information Technology CommunicationsAndInformationTechnology	12578	usd
CY2022Q1	us-gaap	Communications And Information Technology CommunicationsAndInformationTechnology	9456	usd
CY2023Q1	us-gaap	Utilities Operating Expense UtilitiesOperatingExpense	7487	usd
CY2022Q1	us-gaap	Utilities Operating Expense UtilitiesOperatingExpense	7618	usd
CY2023Q1	FSI	Shipping Cost ShippingCost	4666	usd
CY2022Q1	FSI	Shipping Cost ShippingCost	3994	usd
CY2023Q1	FSI	Commissions Commissions	2985	usd
CY2022Q1	FSI	Commissions Commissions	3424	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-2576	usd
CY2022Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-11533	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	1902727	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	1480771	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	1182265	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	2331130	usd
CY2023Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	69995	usd
CY2022Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	36764	usd
CY2023Q1	us-gaap	Interest Income Other InterestIncomeOther	12011	usd
CY2022Q1	us-gaap	Interest Income Other InterestIncomeOther	22088	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1264271	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2389982	usd
CY2023Q1	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	299777	usd
CY2022Q1	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	712446	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	964494	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	1677536	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	80125	usd
CY2022Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	144477	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	884369	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	1533059	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.07
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.12
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12432914	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12361313	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12532404	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12543674	shares
CY2023Q1	us-gaap	Profit Loss ProfitLoss	964494	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	1677536	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-167239	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	42543	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	797255	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	1720079	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	80125	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	144477	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	717130	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1575602	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	964494	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	1677536	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	185298	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	54271	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	342810	usd
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	232488	usd
CY2023Q1	FSI	Lease Right Of Use Financing LeaseRightOfUseFinancing	1745	usd
CY2022Q1	FSI	Lease Right Of Use Financing LeaseRightOfUseFinancing	2539	usd
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	12775	usd
CY2022Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	13546	usd
CY2023Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	69995	usd
CY2022Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	36764	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1383671	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2813819	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-39607	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2712646	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	21497	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	417761	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-179149	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	940734	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	152577	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	712446	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-273223	usd
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-77578	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-228229	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2425008	usd
CY2022Q1	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	7500	usd
CY2023Q1	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	342747	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	213060	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	176684	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-555807	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-169184	usd
CY2023Q1	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	844913	usd
CY2022Q1	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	2647726	usd
CY2023Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	177639	usd
CY2022Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	209629	usd
CY2023Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	14520	usd
CY2022Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	16085	usd
CY2022Q1	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	265922	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	13600	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	56940	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	666354	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2213030	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-167239	usd
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	42543	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-284921	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-338619	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6815099	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6735574	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6530178	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6396955	usd
CY2023Q1	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	5530178	usd
CY2022Q1	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	5371608	usd
CY2023Q1	us-gaap	Short Term Investments ShortTermInvestments	1000000	usd
CY2022Q1	us-gaap	Short Term Investments ShortTermInvestments	1025347	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6530178	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6396955	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	147200	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	134870	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	57618	usd
CY2023Q1	FSI	Inventory Additions In Accounts Payable InventoryAdditionsInAccountsPayable	731020	usd
CY2022Q1	FSI	Inventory Additions In Accounts Payable InventoryAdditionsInAccountsPayable	4242081	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	35238970	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-167239	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	964494	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	13600	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	185298	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	36235123	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	27705476	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	27705476	usd
CY2022Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	42543	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	1677536	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	167222	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	217267	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	12775	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	50045	usd
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	56940	usd
CY2022Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	265922	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	54271	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	29270844	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	29270844	usd
CY2023Q1	us-gaap	Deposits Deposits	700000	usd
CY2023Q1	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.030	pure
CY2023Q1	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	150	usd
CY2023Q1	FSI	Other Term Deposit OtherTermDeposit	300000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.055	pure
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	167222	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	217267	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_849_eus-gaap--UseOfEstimates_z4AGr9tvvtP3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m) <i><span id="xdx_862_zRyprW3E4Y54">Use of Estimates</span></i>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates and would impact the results of operations and cash flows.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 35.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimates and underlying assumptions are reviewed at each period end. Revisions to accounting estimates are recognized in the period in which the estimates are revised and in any future periods affected.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 35.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant areas requiring the use of management estimates include assumptions and estimates relating to the valuation of goodwill and intangible assets, share-based payments, valuation allowances for deferred income tax assets, determination of useful lives of property, equipment and leaseholds and intangible assets, recoverability of accounts receivable, recoverability of investments and the valuation of inventory.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_849_eus-gaap--ConcentrationRiskCreditRisk_ztl8hS84Dtkj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q) <i><span id="xdx_86B_zAC4twpQPBj4">Risk Management</span>.</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s credit risk is primarily attributable to its accounts receivable. The amounts presented in the accompanying consolidated balance sheets are net of allowances for doubtful accounts, estimated by the Company’s management based on prior experience and the current economic environment. The Company is exposed to credit-related losses in the event of non-payment by customers. Credit exposure is minimized by dealing with only credit worthy counterparties. Revenue for the Company’s three primary customers totaled $<span id="xdx_900_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230101__20230331__us-gaap--ConcentrationRiskByTypeAxis__custom--ThreePrimaryCustomersMember_z3rF2i5OOGt3" title="Sales">4,366,106</span> (<span id="xdx_904_ecustom--ConcentrationRiskThresholdPercentage_pid_dp_uPure_c20230101__20230331__us-gaap--ConcentrationRiskByTypeAxis__custom--ThreePrimaryCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember_zJI1hCAgjic3" title="Accounts receivable, after allowance for credit loss">44</span>%) for the three months ended March 31, 2023 (2022 - $<span id="xdx_903_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20220331__us-gaap--ConcentrationRiskByTypeAxis__custom--ThreePrimaryCustomersMember_zKOMMvPh2wxi" title="Sales">6,235,661</span> or <span id="xdx_90B_ecustom--ConcentrationRiskThresholdPercentage_pid_dp_uPure_c20220101__20220331__us-gaap--ConcentrationRiskByTypeAxis__custom--ThreePrimaryCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember_z5OLViFhVK88" title="Accounts receivable, after allowance for credit loss">58</span>%). Accounts receivable for the Company’s three primary customers totaled $<span id="xdx_909_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20230331__us-gaap--ConcentrationRiskByTypeAxis__custom--ThreePrimaryCustomersMember_z1zH2G3k307i" title="Accounts receivable, after allowance for credit loss">6,452,710</span> (<span id="xdx_90E_ecustom--ConcentrationRiskThresholdPercentage_pid_dp_uPure_c20230101__20230331__us-gaap--ConcentrationRiskByTypeAxis__custom--ThreePrimaryCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zvK6ufk4dtEi" title="Accounts receivable, after allowance for credit loss, percentage">59</span>%) at March 31, 2023 (December 31, 2022 - $<span id="xdx_904_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20221231__us-gaap--ConcentrationRiskByTypeAxis__custom--ThreePrimaryCustomersMember_zgerE7T4EDpk" title="Accounts receivable, after allowance for credit loss">6,124,424</span> or <span id="xdx_90F_ecustom--ConcentrationRiskThresholdPercentage_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__custom--ThreePrimaryCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zOoREpbu1FYa" title="Accounts receivable, after allowance for credit loss, percentage">65</span>%).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The credit risk on cash is limited because the Company limits its exposure to credit loss by placing its cash with major financial institutions. The Company maintains cash balances at financial institutions which at times exceed federally insured amounts. The Company has not experienced any losses in such accounts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is exposed to foreign exchange and interest rate risk to the extent that market value rate fluctuations materially differ from financial assets and liabilities, subject to fixed long-term rates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In order to manage its exposure to foreign exchange risks, the Company is closely monitoring the fluctuations in the foreign currency exchange rates and the impact on the value of cash, accounts receivable, and accounts payable and accrued liabilities. The Company has not hedged its exposure to currency fluctuations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is exposed to interest rate risk to the extent that the fair value or future cash flows for financial liabilities will fluctuate as a result of changes in market interest rates. The Company is exposed to interest rate risk on its long-term debt.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In order to manage its exposure to interest rate risk, the Company is closely monitoring fluctuations in market interest risks and will refinance its long-term debt where possible to obtain more favourable rates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	154447	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	167222	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	154447	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	167222	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	167222	usd
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	217267	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	167222	usd
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	217267	usd
CY2023Q1	FSI	Lease Interest Expense LeaseInterestExpense	1745	usd
CY2022	FSI	Lease Interest Expense LeaseInterestExpense	8566	usd
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	14520	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	58611	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	154447	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	167222	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	154447	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	167222	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	58440	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	58080	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	96007	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	109142	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	154447	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	167222	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	43560	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	59520	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	61020	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	164100	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	9653	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	154447	usd
CY2023Q1	us-gaap	Accounts Receivable Gross AccountsReceivableGross	11122850	usd
CY2022Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	9739150	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	289323	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	289293	usd
CY2023Q1	us-gaap	Accounts And Notes Receivable Net AccountsAndNotesReceivableNet	10833527	usd
CY2022Q4	us-gaap	Accounts And Notes Receivable Net AccountsAndNotesReceivableNet	9449857	usd
CY2023Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	3764498	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	3806646	usd
CY2023Q1	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	10615325	usd
CY2022Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	10612784	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	14379823	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	14419430	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	18635305	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	9015767	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	9619538	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	18399675	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	8690387	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	9709288	usd
CY2023Q1	us-gaap	Depreciation Depreciation	302810	usd
CY2022	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	3230798	usd
CY2022	FSI	Proceeds From Loan Acquired From Acquisition ProceedsFromLoanAcquiredFromAcquisition	2849500	usd
CY2023Q1	us-gaap	Payments For Proceeds From Deposit On Loan PaymentsForProceedsFromDepositOnLoan	177639	usd
CY2022	us-gaap	Payments For Proceeds From Deposit On Loan PaymentsForProceedsFromDepositOnLoan	2292819	usd
CY2022Q1	us-gaap	Depreciation Depreciation	188378	usd
CY2023Q1	us-gaap	Finite Lived Patents Gross FiniteLivedPatentsGross	195888	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	195888	usd
CY2022Q4	us-gaap	Finite Lived Patents Gross FiniteLivedPatentsGross	195725	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	195725	usd
CY2023Q1	us-gaap	Goodwill Goodwill	2534275	usd
CY2022Q4	us-gaap	Goodwill Goodwill	2534275	usd
CY2021Q4	us-gaap	Goodwill Goodwill	2534275	usd
CY2023Q1	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	770000	usd
CY2022Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	770000	usd
CY2021Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	770000	usd
CY2023Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	351287	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	8540	usd
CY2022	us-gaap	Business Combination Consideration Transferred1 BusinessCombinationConsiderationTransferred1	506659	usd
CY2022Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents	7330	usd
CY2022Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Buildings BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings	3750000	usd
CY2022Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Land BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand	150000	usd
CY2022Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Deferred Tax Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities	174582	usd
CY2022Q4	FSI	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Long Term Debt BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt	-2849500	usd
CY2022Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets	883248	usd
CY2022Q4	FSI	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Less Purchase Price BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLessPurchasePrice	376589	usd
CY2022	FSI	Investment Eliminated Upon Consolidation InvestmentEliminatedUponConsolidation	-41538	usd
CY2022	FSI	Gain On Acquisition Of Subsidiary GainOnAcquisitionOfSubsidiary	335051	usd
CY2021	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2023-12-06
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	6154077	usd
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	2366598	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	6154077	usd
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	2366598	usd
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	5976438	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	6154077	usd
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	5976438	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	6154077	usd
CY2023Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	719607	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	717612	usd
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	5256831	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	5436465	usd
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights Percentage SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage	1	pure
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod	P5Y
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	789500	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.78
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	981000	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	3.55
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	13486	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	2.32
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	71014	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.98
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1686000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.26
CY2023Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	8000	shares
CY2023Q1	FSI	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Excercised Options Exercise Price SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExcercisedOptionsExercisePrice	1.70
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.70
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1678000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.27
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	672000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.94
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y10M24D
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P3Y
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	1251732	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y4M24D
CY2023Q1	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	1272	shares
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	4070	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	9847517	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10783280	usd
CY2023Q1	us-gaap	Noncurrent Assets NoncurrentAssets	14708260	usd
CY2022Q4	us-gaap	Noncurrent Assets NoncurrentAssets	14850786	usd

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001493152-23-017255-index-headers.html	Edgar Link	pending
0001493152-23-017255-index.html	Edgar Link	pending
0001493152-23-017255.txt	Edgar Link	pending
0001493152-23-017255-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
fsi-20230331.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
fsi-20230331_cal.xml	Edgar Link	unprocessable
fsi-20230331_def.xml	Edgar Link	unprocessable
fsi-20230331_lab.xml	Edgar Link	unprocessable
fsi-20230331_pre.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$FSI
FLEXIBLE SOLUTIONS INTERNATIONAL INC Stock $fsi

2023 Q2 Form 10-Q Financial Statement

#000149315223017255 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FSI FLEXIBLE SOLUTIONS INTERNATIONAL INC Stock $fsi

2023 Q2 Form 10-Q Financial Statement

#000149315223017255 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FSI
FLEXIBLE SOLUTIONS INTERNATIONAL INC Stock $fsi